113 related articles for article (PubMed ID: 9678717)
21. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
22. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Damle RN; Batliwalla FM; Ghiotto F; Valetto A; Albesiano E; Sison C; Allen SL; Kolitz J; Vinciguerra VP; Kudalkar P; Wasil T; Rai KR; Ferrarini M; Gregersen PK; Chiorazzi N
Blood; 2004 Jan; 103(2):375-82. PubMed ID: 14504108
[TBL] [Abstract][Full Text] [Related]
23. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
[TBL] [Abstract][Full Text] [Related]
24. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
[TBL] [Abstract][Full Text] [Related]
25. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
[TBL] [Abstract][Full Text] [Related]
27. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
Giannoni P; Cutrona G; Totero D
Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
29. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.
Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A
J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328
[TBL] [Abstract][Full Text] [Related]
30. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
31. Cytokine expression in B-CLL in relation to disease progression and in vitro activation.
Aguilar-Santelises M; Gigliotti D; Osorio LM; Santiago AD; Mellstedt H; Jondal M
Med Oncol; 1999 Dec; 16(4):289-95. PubMed ID: 10618692
[TBL] [Abstract][Full Text] [Related]
32. Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL).
Aguilar-Santelises M; Amador JF; Mellstedt H; Jondal M
Leuk Res; 1989; 13(10):937-42. PubMed ID: 2586147
[TBL] [Abstract][Full Text] [Related]
33. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
Scaglione BJ; Salerno E; Balan M; Coffman F; Landgraf P; Abbasi F; Kotenko S; Marti GE; Raveche ES
Br J Haematol; 2007 Dec; 139(5):645-57. PubMed ID: 17941951
[TBL] [Abstract][Full Text] [Related]
34. Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro.
Zhu F; McCaw L; Spaner DE; Gorczynski RM
Leuk Res; 2018 Mar; 66():28-38. PubMed ID: 29353760
[TBL] [Abstract][Full Text] [Related]
35. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343
[TBL] [Abstract][Full Text] [Related]
36. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic alterations in a murine model for chronic lymphocytic leukemia.
Chen SS; Sherman MH; Hertlein E; Johnson AJ; Teitell MA; Byrd JC; Plass C
Cell Cycle; 2009 Nov; 8(22):3663-7. PubMed ID: 19901553
[TBL] [Abstract][Full Text] [Related]
38. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes.
Saunders FK; Sharrard RM; Winfield DA; Lawry J; Goepel JR; Hancock BW; Goyns MH
Leuk Res; 1993 Mar; 17(3):223-30. PubMed ID: 7680735
[TBL] [Abstract][Full Text] [Related]
39. PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia.
Spaner DE; Lee E; Shi Y; Wen F; Li Y; Tung S; McCaw L; Wong K; Gary-Gouy H; Dalloul A; Ceddia R; Gorzcynski R
Leukemia; 2013 Apr; 27(5):1090-9. PubMed ID: 23160450
[TBL] [Abstract][Full Text] [Related]
40. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
